Stock listing

NASDAQ:CLNN Clene Inc. Stock

Home listing (NASDAQ) of Clene Inc.

Follow Clene Inc. into a list and get an email when it puts out news.

Share price · NASDAQ:CLNN

$3.52 USD +0.10 (+2.9%)

Close on Nov 20, 2026

Past year -59.8% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$3.30 – $3.60 USDNov 20, 2026
Volume
143,565 sharesNov 20, 2026
Market cap
$50.69M USDAt the close on Nov 20, 2026 · price × 14.40M shares outstanding
52-week range
$3.02 – $10.84 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$436,932 USDMedian day 107,600 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
Clene Inc. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:CLNN · Home$3.52 USD+0.10 (+2.9%)143,565$3.41$3.60$3.30$3.42Close on Nov 20, 2026
Frankfurt:84C0€3.10 EUR+0.06 (+2.0%)—€3.10€3.10€3.10€3.04Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:CLNN · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$3.52+0.10+2.9%$3.41$3.60$3.30143,565
$3.42+0.20+6.2%$3.23$3.59$3.10239,332
$3.22-0.44-12.0%$3.71$3.71$3.105204,947
$3.66-0.26-6.6%$3.86$3.92$3.54123,344
$3.92-0.08-2.0%$4.43$4.43$3.8628,739
$4.00-0.195-4.6%$4.16$4.25$3.92109,045
$4.195-0.215-4.9%$4.38$4.566$4.17208,437
$4.41+0.03+0.7%$4.40$4.81$4.38145,314
$4.38+0.43+10.9%$3.97$4.93$3.97201,466
$3.95-0.02-0.5%$3.96$4.11$3.75560,703
$3.97-0.13-3.2%$4.04$4.24$3.675116,944
$4.10+0.33+8.8%$3.93$4.24$3.805114,945
$3.77+0.16+4.4%$3.65$3.90$3.6544,308
$3.61-0.22-5.7%$3.85$3.925$3.60554,013
$3.83-0.07-1.8%$3.75$3.95$3.7547,081
$3.90-0.13-3.2%$3.97$3.99$3.8734,114
$4.03+0.06+1.5%$3.96$4.05$3.9043,856
$3.97+0.13+3.4%$3.84$3.99$3.8431,272
$3.84-0.04-1.0%$3.92$3.92$3.7833,858
$3.880.000.0%$3.79$3.97$3.7721,396
$3.88+0.12+3.2%$3.73$4.01$3.63124,247
$3.76+0.03+0.8%$3.76$4.00$3.7184,562
$3.73+0.44+13.4%$3.52$4.05$3.196202,009
$3.29+0.19+6.1%$3.30$3.391$3.1088,490
$3.10-0.21-6.3%$3.39$3.39$3.02204,400
$3.310.000.0%$3.25$3.44$3.20134,000
$3.31-0.08-2.4%$3.38$3.40$3.2471,400
$3.39-0.29-7.9%$3.69$3.70$3.36114,700
$3.68-0.18-4.7%$3.93$3.93$3.6773,700
$3.86-0.02-0.5%$3.83$3.96$3.8048,100
$3.88-0.04-1.0%$3.94$3.96$3.7782,300
$3.92+0.05+1.3%$3.85$4.01$3.7140,500
$3.87-0.04-1.0%$3.92$4.04$3.8045,000
$3.91-0.17-4.2%$4.09$4.11$3.80278,200
$4.08+0.06+1.5%$4.08$4.17$3.9761,500
$4.02-0.06-1.5%$4.10$4.15$4.00100,000
$4.08-0.02-0.5%$4.14$4.33$4.0151,800
$4.10+0.04+1.0%$4.10$4.26$4.0670,400
$4.06-0.24-5.6%$4.24$4.37$4.0191,700
$4.30+0.09+2.1%$4.15$4.49$4.12136,400
$4.21-0.08-1.9%$4.27$4.38$4.0947,700
$4.29-0.09-2.1%$4.36$4.44$4.1575,200
$4.38-0.16-3.5%$4.51$4.70$4.27135,800
$4.54+0.19+4.4%$4.40$4.70$4.40108,900
$4.35+0.20+4.8%$4.16$4.44$4.05191,400
$4.15+0.29+7.5%$3.86$4.23$3.81138,800
$3.86-0.16-4.0%$4.05$4.37$3.84255,800
$4.02+0.74+22.6%$3.25$4.18$3.25478,800
$3.28-0.29-8.1%$3.57$3.72$3.26140,900
$3.57-0.08-2.2%$3.72$3.76$3.52125,000
$3.65-0.07-1.9%$3.67$3.93$3.61113,000
$3.72+0.10+2.8%$3.67$3.84$3.48159,300
$3.62-0.23-6.0%$3.82$3.82$3.60252,600
$3.85-0.15-3.7%$3.92$4.00$3.72122,600
$4.00-0.16-3.8%$4.18$4.22$3.75145,000
$4.16+0.05+1.2%$4.10$4.28$3.88107,600
$4.11-0.17-4.0%$4.22$4.42$4.02159,100
$4.28+0.05+1.2%$4.31$4.32$4.1141,300
$4.23-0.24-5.4%$4.43$4.74$4.1759,700
$4.47-0.18-3.9%$4.67$4.80$4.4033,000
$4.65+0.21+4.7%$4.43$4.75$4.2689,900
$4.44+0.005+0.1%$4.47$4.58$4.20112,100
$4.435+0.115+2.7%$4.31$4.53$4.2437,313
$4.32-0.05-1.1%$4.40$4.41$4.1328,900
$4.37+0.18+4.3%$4.24$4.37$4.1023,100

Splits

1 split · NASDAQ:CLNN · every price before a split is adjusted for it

DayRatioWhat
1-for-20Consolidation
Ticker
NASDAQ:CLNN
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
NASDAQ
Currency
USD

What changed lately

Latest news

All Clene Inc. news

Financings

  • Registered direct offering of common stock

    Sep 21, 2026

    Closed: US$4M raised · US$3.28 a share

    Buyers: David Matlin (Led the offering); Kensington Capital Holdings

    Insiders: Led by the Chairman of the Board, David Matlin, alongside the Chief Executive Officer and other existing shareholders including insiders

    Use of proceeds: Fund operations through mid-first quarter 2027, beyond the potential FDA decision on accepting the CNM-Au8 NDA for review

    Announced Sep 15, 2026 · Closed Sep 21, 2026

  • Registered direct offering of common stock

    May 5, 2026

    Announced: about US$7M · US$7 a share · Canaccord Genuity LLC

    Dealers: Canaccord Genuity LLC (lead)

    Use of proceeds: General corporate purposes, NDA filing for CNM-Au8, expanded access and Phase 3 trial, manufacturing expansion, commercialization and early-stage R&D

    Announced May 5, 2026

  • Registered direct offering of common stock with Series A and Series B warrants

    Jan 9, 2026

    Announced: about US$28M · US$6.5 a share · Warrants at US$6 · BTIG, LLC

    Dealers: BTIG, LLC (lead)

    Buyers: Boxer Capital; Coastlands Capital; Vivo Capital

    Insiders: Offering priced above market to new, existing and insider investors, including other current insider investors

    Use of proceeds: Fund operations through potential FDA NDA acceptance and approval and commercialization of CNM-Au8 in ALS

    Announced Jan 9, 2026

  • Not stated

    Nov 13, 2025

    Closed: US$1.2M raised

    Use of proceeds: Fund operations into the second quarter of 2026

    Closed Nov 13, 2025

  • Equity

    Aug 14, 2025

    Closed: US$1.9M raised

    Use of proceeds: To fund operations into the first quarter of 2026

    Closed Aug 14, 2025

  • Convertible debt facility

    Aug 14, 2025

    Made bigger: US$1.5M

    Use of proceeds: To fund operations into the first quarter of 2026

    Made bigger Aug 14, 2025

  • Secured, partially convertible note

    Dec 19, 2024

    Announced: US$10M

    Insiders: The note was signed with three entities, all of which are affiliated with Clene

    Use of proceeds: Repay the remaining Avenue Capital senior loan and extend cash runway to generate data for the CNM-Au8 ALS drug application

    Announced Dec 19, 2024

Read by 6ix AI from the company's releases

Decks

Clene Inc. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
19 in the last 12 months · 126 in all · newest Nov 4, 2026 · oldest 2021
Decks
44 decks · latest Aug 10, 2026

Where Clene Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:CLNN · Home listing · This pageNASDAQUnited StatesUSD
BOATS:CLNNBOATSUnited StatesUSD
Frankfurt:84C0FrankfurtGermanyEUR
Tradegate:84C0TradegateGermanyEUR

Log in to ask 6ix AI your own questions about Clene Inc.